https://www.selleckchem.com/products/10058-f4.html
Linagliptin is a convenient and effective drug approved for glycemic management in type 2 diabetes mellitus (T2DM). However, the effectiveness and safety evidence of linagliptin remains unclear with the increasing prevalence of T2DM in elderly patients. For evaluating the effectiveness and safety of linagliptin within T2DM cases who aged ≥60 years. The researchers pooled 4903 cases aged ≥60 years with T2DM from 5 published randomized clinical trials obtained from multiple databases. The safety was evaluated by the incidence and severit
إعجاب
علق
شارك
